Total Payments
$4,040
2024 Payments
$900.34
Companies
32
Transactions
128
Medicare Patients
734
Medicare Billing
$52,594
Payment Breakdown by Category
Food & Beverage$3,697 (91.5%)
Travel$342.93 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,697 | 126 | 91.5% |
| Travel and Lodging | $342.93 | 2 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,063 | 8 | $0 (2023) |
| Biogen, Inc. | $319.35 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $280.84 | 24 | $0 (2024) |
| Neurelis, Inc. | $202.90 | 6 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $169.85 | 4 | $0 (2022) |
| Eisai Inc. | $167.80 | 3 | $0 (2024) |
| BANNER LIFE SCIENCES, LLC | $158.52 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $156.54 | 3 | $0 (2023) |
| TG Therapeutics, Inc. | $131.92 | 6 | $0 (2024) |
| Inspire Medical Systems, Inc. | $118.51 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $900.34 | 35 | Eisai Inc. ($145.78) |
| 2023 | $2,469 | 73 | LivaNova USA, Inc. ($965.43) |
| 2022 | $670.66 | 20 | Biohaven Pharmaceutical Holding Company Ltd. ($169.85) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Neurology | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Immunology | ||||||
| 08/19/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Immune | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Neurology | ||||||
| 07/18/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Neurology | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Neurology | ||||||
| 05/22/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Neurology | ||||||
| 05/08/2024 | Acorda Therapeutics, Inc | AMPYRA (Drug), INBRIJA | Food and Beverage | Cash or cash equivalent | $29.03 | General |
| Category: Multiple Sclerosis | ||||||
| 05/03/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Neurology | ||||||
| 05/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Neurology | ||||||
| 04/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Neurology | ||||||
| 04/10/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Neurology | ||||||
| 03/29/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Rare Disease | ||||||
| 03/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Neurology | ||||||
| 03/20/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Immunology | ||||||
| 03/08/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 377 | 795 | $95,102 | $31,647 |
| 2022 | 2 | 49 | 115 | $11,500 | $3,284 |
| 2020 | 10 | 308 | 346 | $39,180 | $17,663 |
Total Patients
734
Total Services
1,256
Medicare Billing
$52,594
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 166 | 434 | $43,400 | $13,227 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 182 | $24,024 | $8,956 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 56 | 87 | $13,175 | $4,728 | 35.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 35 | 49 | $8,673 | $2,554 | 29.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 16 | $2,944 | $1,208 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 27 | $2,886 | $974.82 | 33.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 24 | 88 | $8,800 | $2,138 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 25 | 27 | $2,700 | $1,147 | 42.5% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2020 | 104 | 118 | $14,211 | $6,399 | 45.0% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Office | 2020 | 32 | 34 | $4,013 | $1,814 | 45.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2020 | 34 | 43 | $3,652 | $1,621 | 44.4% |
| 99345 | New patient home visit, typically 75 minutes | Office | 2020 | 11 | 11 | $3,491 | $1,487 | 42.6% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2020 | 32 | 41 | $2,931 | $1,327 | 45.3% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 18 | 18 | $2,878 | $1,300 | 45.2% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 38 | 42 | $2,465 | $1,111 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $1,962 | $1,100 | 56.0% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2020 | 11 | 11 | $2,162 | $919.43 | 42.5% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2020 | 16 | 16 | $1,416 | $584.84 | 41.3% |
About Folake Aje
Folake Aje is a Nurse Practitioner healthcare provider based in Highland, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2020. The National Provider Identifier (NPI) number assigned to this provider is 1952936114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Folake Aje has received a total of $4,040 in payments from pharmaceutical and medical device companies, with $900.34 received in 2024. These payments were reported across 128 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,697).
As a Medicare-enrolled provider, Aje has provided services to 734 Medicare beneficiaries, totaling 1,256 services with total Medicare billing of $52,594. Data is available for 3 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Highland, IN
- Active Since 03/09/2020
- Last Updated 07/08/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952936114
Products in Payments
- VNS Therapy (Device) $910.02
- KESIMPTA (Drug) $207.73
- VALTOCO (Drug) $202.90
- NURTEC ODT (Drug) $169.85
- BAFIERTAM (Drug) $158.52
- TYSABRI (Biological) $154.74
- Leqembi (Drug) $145.78
- VUMERITY (Drug) $140.47
- REXULTI (Drug) $138.39
- BRIUMVI (Drug) $131.92
- INSPIRE (Device) $118.51
- REBLOZYL (Biological) $116.37
- Sunosi (Drug) $99.04
- VNS Therapy SenTiva Model 1000 Generator (Device) $97.48
- Tymlos (Drug) $87.91
- Briviact (Drug) $81.64
- MAYZENT (Drug) $73.11
- AMYVID (Drug) $61.18
- SOLIRIS (Biological) $59.96
- XYWAV (Drug) $58.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Highland
Megan Colburn, Np, NP
Nurse Practitioner — Payments: $956.98
Nurse Practitioner $956.98
Emma Dragovich, Aprn, APRN
Nurse Practitioner — Payments: $698.51
Nurse Practitioner $698.51
Tara Colledge, Aprn, APRN
Nurse Practitioner — Payments: $677.11
Nurse Practitioner $677.11
Mrs. Nicole Lopez, Fnp-C, FNP-C
Nurse Practitioner — Payments: $528.05
Nurse Practitioner $528.05
Monica Alvarez, Fnp-C, FNP-C
Nurse Practitioner — Payments: $508.62
Nurse Practitioner $508.62
Gina Crusor-Price, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $492.35
Nurse Practitioner $492.35